ReviewFrontiers in oncology2014
Radiotherapy for thymic carcinoma: adjuvant, inductive, and definitive.
Review in Frontiers in oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 36 citations in OpenAlex.
- Patterns of care in the use of radiotherapy for thymoma: a TROD thoracic oncology working group survey (TROD 08-013).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Management of liver metastases secondary to thymic epithelial tumors: a narrative review of current management and future directions.Mediastinum (Hong Kong, China) · 2026Review
- Dose and normal tissue complication probability analysis of various radiotherapy regimens for thymomas.Frontiers in oncology · 2026Article
- The role of adjuvant chemotherapy in patients with thymoma and thymic carcinoma following surgery: a systematic literature review and meta-analysis.Journal of thoracic disease · 2025Article
- Long-term survival and prognosis after surgical treatment of patients with thymic carcinoma: a retrospective analysis.Journal of thoracic disease · 2024Article
- Comparison of radiotherapy techniques in patients with thymic epithelial tumor who underwent postoperative radiotherapy.Radiation oncology journal · 2024Article
- Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies.Frontiers in oncology · 2022Article
- Radiotherapy for thymic epithelial tumours: a review.Translational lung cancer research · 2021Review
- Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.International journal of molecular sciences · 2020Review
- Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.Journal of cancer research and clinical oncology · 2020Article
- Review
- A bimodal approach to thymic carcinoma with pericardial sac invasion.BMJ case reports · 2019Article
- Rationale and early outcomes for the management of thymoma with proton therapy.Translational lung cancer research · 2018Article
- Prospective Study of Stereotactic Body Radiation Therapy for Thymoma and Thymic Carcinoma: Therapeutic Effect and Toxicity Assessment.Scientific reports · 2017Article
- Chemoradiotherapy for unresectable cases of thymic epithelial tumors: a retrospective study.Journal of thoracic disease · 2017Article
- Article
- A Single-Institution Analysis of Thymic Carcinoma Treated with Multi-Modality Therapy.Annals of radiation therapy and oncology · 2017Article
- Preoperative Proton Beam Therapy for Thymoma: A Case Report.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2016Article
- Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies.OncoTargets and therapy · 2016Article
- Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution.General thoracic and cardiovascular surgery · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although historically thymoma and thymic carcinoma have been treated surgically, radiation therapy also has an important role, either as postoperative therapy to reduce the risk of mediastinal recurrence or as part of definitive treatment for patients who cannot undergo surgery. Induction chemotherapy and molecular targeted agents may also be appropriate for thymic carcinoma, the behavior of which resembles non-small-cell lung carcinoma more than that of thymoma or invasive thymoma and is increasingly being treated like lung cancer. We present here a review of current therapies for thymic malignancies and briefly discuss the potential benefits from novel technologies for such treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.